0.52 INR
114.55 M INR
4.64 B INR
90.29 M
About SUDARSHAN PHARMA INDUSTRIES LI
Sector
Headquarters
Mumbai
Founded
2008
Website
ISIN
INE00TV01023
FIGI
BBG00PDZ3ZC8
Sudarshan Pharma Industries Ltd. engages in the provision of specialty chemicals, intermediates, and active pharmaceuticals ingredients. The firm outsourced its supplies to provide products to clients in India and abroad. It also involved in contract manufacturing, outsource and supplies of generic pharma formulation, and medicines to healthcare institution, government, NGO, and hospitals. The company was founded on July 23, 2008 and is headquartered in Mumbai, India.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SUDARSHAN is 43.39 INR — it has increased by 4.58% in the past 24 hours. Watch SUDARSHAN PHARMA INDUSTRIES LI stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SUDARSHAN PHARMA INDUSTRIES LI stocks are traded under the ticker SUDARSHAN.
SUDARSHAN stock has risen by 9.57% compared to the previous week, the month change is a 5.32% rise, over the last year SUDARSHAN PHARMA INDUSTRIES LI has showed a 429.34% increase.
SUDARSHAN reached its all-time high on Nov 25, 2024 with the price of 46.00 INR, and its all-time low was 5.18 INR and was reached on Mar 31, 2023. View more price dynamics on SUDARSHAN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SUDARSHAN stock is 10.25% volatile and has beta coefficient of 1.21. Track SUDARSHAN PHARMA INDUSTRIES LI stock price on the chart and check out the list of the most volatile stocks — is SUDARSHAN PHARMA INDUSTRIES LI there?
Yes, you can track SUDARSHAN PHARMA INDUSTRIES LI financials in yearly and quarterly reports right on TradingView.
SUDARSHAN net income for the last half-year is 59.23 M INR, while the previous report showed 66.03 M INR of net income which accounts for −10.29% change. Track more SUDARSHAN PHARMA INDUSTRIES LI financial stats to get the full picture.
Yes, SUDARSHAN dividends are paid annually. The last dividend per share was 0.30 INR. As of today, Dividend Yield (TTM)% is 0.08%. Tracking SUDARSHAN PHARMA INDUSTRIES LI dividends might help you take more informed decisions.
SUDARSHAN PHARMA INDUSTRIES LI dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.54% and 5.48% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 65.00 employees. See our rating of the largest employees — is SUDARSHAN PHARMA INDUSTRIES LI on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUDARSHAN PHARMA INDUSTRIES LI EBITDA is 309.79 M INR, and current EBITDA margin is 4.95%. See more stats in SUDARSHAN PHARMA INDUSTRIES LI financial statements.
Like other stocks, SUDARSHAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUDARSHAN PHARMA INDUSTRIES LI stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUDARSHAN PHARMA INDUSTRIES LI technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUDARSHAN PHARMA INDUSTRIES LI stock shows the buy signal. See more of SUDARSHAN PHARMA INDUSTRIES LI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.